文献速递心力衰竭与心肌病心律失常

慢性射血分数降低心衰患者心源性猝死的机制解析

What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?
PubMed 文献 · Eur Heart J · 2020-01-01

该文综述探讨慢性射血分数降低心衰患者中30-50%发生猝死的机制,提出多数无急性触发因素,而由左室重构与纤维化形成易损基质,以「自组织临界性」模型解释级联衰竭导致急性循环崩溃,并区分ICD可终止与不可终止的猝死类型。

要点

  • 慢性HFrEF患者中30-50%的死亡为猝死。
  • 多数猝死无急性触发机制,基质为左室重构与纤维化。
  • 自组织临界性模型解释无触发事件的级联衰竭致猝死。

核心结论

  • 慢性HFrEF患者多数猝死无急性触发因素,由左室重构和纤维化形成易损基质,以自组织临界性模型解释级联衰竭致急性循环崩溃。

研究设计与样本

  • 综述性文章,基于理论物理中的自组织临界性模型,阐述慢性HFrEF患者猝死的病理生理机制。

主要发现

  • 慢性HFrEF患者中30-50%的死亡为猝死。
  • 多数猝死无急性触发机制,如心肌梗死、儿茶酚胺 surge 或电解质失衡。
  • 自组织临界性模型下,心室肌对进行性应激和牵张的适应最终导致级联衰竭。
  • 级联衰竭可表现为首次室性快速性心律失常,对ICD电击有反应。
  • 级联衰竭也可表现为急性机械衰竭,如无收缩、缓慢性心律失常、电机械分离或持续性室颤,ICD无法预防。

临床怎么用

  • 抗重构和抗纤维化干预(神经激素拮抗剂和心脏再同步化)可降低无ICD患者的猝死风险,并对有ICD患者提供增量获益。
  • 抗重构和抗纤维化治疗可能解释过去10-15年心衰临床试验中猝死发生率显著下降,独立于ICD使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sudden death characterizes the mode of demise in 30-50% of patients with chronic heart failure and a reduced ejection fraction. Occasionally, these events have an identifiable pathophysiological trigger, e.g. myocardial infarction, catecholamine surges, or electrolyte imbalances, but in most circumstances, there is no acute precipitating mechanism. Instead, adverse left ventricular remodelling and fibrosis creates an exceptionally fragile and highly vulnerable substrate, which can be characterized using the model developed in theoretical physics of 'self-organizing criticality'. This framework has been applied to describe the genesis of avalanches, nodes of traffic congestion unrelated to an accident, the abrupt system-wide failure of electrical grids, and the initiation of cancer and neurodegenerative diseases. Self-organizing criticality within the ventricular myocardium relies on complex adaptations to progressive stress and stretch, which evolve inevitably to an abrupt end (termed 'cascading failure'), even though the rate of deterioration of the underlying disease process has not changed. The result is acute circulatory collapse (i.e. sudden death) in the absence of an identifiable triggering event. Cascading failure in a severely remodelled or fibrotic heart can become manifest electrically as a first-time ventricular tachyarrhythmia that is responsive to the shock delivered by an implantable cardioverter-defibrillator (ICD). Alternatively, it may present as an acute mechanical failure, which is manifest as (i) asystole, bradyarrhythmia, or electromechanical dissociation; or (ii) incessant ventricular fibrillation that persists despite repetitive ICD discharges; in both instances, the sudden deaths cannot be prevented by an ICD. This conceptual framework explains why anti-remodelling and antifibrotic interventions (i.e. neurohormonal antagonists and cardiac resynchronization) reduce the risk of sudden death in patients with heart failure in the absence of an ICD and provide incremental benefits in those with an ICD. The adoption of anti-remodelling and antifibrotic treatments may explain why the incidence of sudden death in clinical trials of heart failure has declined dramatically over the past 10-15 years, independent of the use of ICDs.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Packer M. What causes sudden death in patients with chronic heart failure and a reduced ejection fraction? Eur Heart J. 2020. PMID: 31390006. doi:10.1093/eurheartj/ehz553

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。